Progress in unraveling the genetic etiology of Parkinson disease in a genomic era
- PMID: 25703649
- DOI: 10.1016/j.tig.2015.01.004
Progress in unraveling the genetic etiology of Parkinson disease in a genomic era
Abstract
Parkinson disease (PD) and Parkinson-plus syndromes are genetically heterogeneous neurological diseases. Initial studies into the genetic causes of PD relied on classical molecular genetic approaches in well-documented case families. More recently, these approaches have been combined with exome sequencing and together have identified 15 causal genes. Additionally, genome-wide association studies (GWASs) have discovered over 25 genetic risk factors. Elucidation of the genetic architecture of sporadic and familial parkinsonism, however, has lagged behind that of simple Mendelian conditions, suggesting the existence of features confounding genetic data interpretation. Here we discuss the successes and potential pitfalls of gene discovery in PD and related disorders in the post-genomic era. With an estimated 30% of trait variance currently unexplained, tackling current limitations will further expedite gene discovery and lead to increased application of these genetic insights in molecular diagnostics using gene panel and exome sequencing strategies.
Keywords: Parkinson disease; gene identification studies; limitations; massive parallel sequencing; molecular diagnostics.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
-
Role of genomics in translational research for Parkinson's disease.Biochem Biophys Res Commun. 2014 Sep 19;452(2):226-35. doi: 10.1016/j.bbrc.2014.06.028. Epub 2014 Jun 17. Biochem Biophys Res Commun. 2014. PMID: 24950403 Review.
-
Whole-exome/genome sequencing and genomics.Pediatrics. 2013 Dec;132(Suppl 3):S211-5. doi: 10.1542/peds.2013-1032E. Pediatrics. 2013. PMID: 24298129
-
Genetics of Parkinson's disease: the yield.Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S35-8. doi: 10.1016/S1353-8020(13)70011-7. Parkinsonism Relat Disord. 2014. PMID: 24262184 Review.
-
[Present efforts in the medical genome center at the University of Tokyo Hospital].Brain Nerve. 2013 Mar;65(3):247-55. Brain Nerve. 2013. PMID: 23475516 Review. Japanese.
-
Developing genome and exome sequencing for candidate gene identification in inherited disorders: an integrated technical and bioinformatics approach.Arch Pathol Lab Med. 2013 Mar;137(3):415-33. doi: 10.5858/arpa.2012-0107-RA. Epub 2012 Jul 7. Arch Pathol Lab Med. 2013. PMID: 22770468 Review.
Cited by
-
Protective mechanism of Syringic acid in an experimental model of Parkinson's disease.Metab Brain Dis. 2021 Jun;36(5):1003-1014. doi: 10.1007/s11011-021-00704-9. Epub 2021 Mar 5. Metab Brain Dis. 2021. PMID: 33666819
-
The Anti-Parkinson Potential of Gingko biloba-Supplement Mitigates Cortico-Cerebellar Degeneration and Neuropathobiological Alterations via Inflammatory and Apoptotic Mediators in Mice.Neurochem Res. 2022 Aug;47(8):2211-2229. doi: 10.1007/s11064-022-03600-5. Epub 2022 May 9. Neurochem Res. 2022. PMID: 35532872
-
Synergistic Effect of Mitochondrial and Lysosomal Dysfunction in Parkinson's Disease.Cells. 2019 May 14;8(5):452. doi: 10.3390/cells8050452. Cells. 2019. PMID: 31091796 Free PMC article.
-
Uncovering the Role of Natural and Synthetic Small Molecules in Counteracting the Burden of α-Synuclein Aggregates and Related Toxicity in Different Models of Parkinson's Disease.Int J Mol Sci. 2023 Aug 29;24(17):13370. doi: 10.3390/ijms241713370. Int J Mol Sci. 2023. PMID: 37686175 Free PMC article. Review.
-
Deconvoluting the complexity of autophagy and Parkinson's disease for potential therapeutic purpose.Oncotarget. 2015 Dec 1;6(38):40480-95. doi: 10.18632/oncotarget.5803. Oncotarget. 2015. PMID: 26415234 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical